Evidence-Based Medicine Guidelines
Speech and language therapy for dysarthria in Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Speech and Language Therapy for Dysarthria in Parkinson's Disease." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453538/all/Speech_and_language_therapy_for_dysarthria_in_Parkinson&apos.
Speech and language therapy for dysarthria in Parkinson's disease. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/453538/all/Speech_and_language_therapy_for_dysarthria_in_Parkinson&apos. Accessed February 9, 2026.
Speech and language therapy for dysarthria in Parkinson's disease. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/453538/all/Speech_and_language_therapy_for_dysarthria_in_Parkinson&apos
Speech and Language Therapy for Dysarthria in Parkinson's Disease [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2026 February 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453538/all/Speech_and_language_therapy_for_dysarthria_in_Parkinson&apos.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Speech and language therapy for dysarthria in Parkinson's disease
ID - 453538
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453538/all/Speech_and_language_therapy_for_dysarthria_in_Parkinson&apos
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
